Innovation America Innovation America Accelerating the growth of the GLOBAL entrepreneurial innovation economy
Founded by Rich Bendis

innovation DAILY

Here we highlight selected innovation related articles from around the world on a daily basis.  These articles related to innovation and funding for innovative companies, and best practices for innovation based economic development.


The Maryland Life Sciences Advisory Board (LSAB) today announced a series of strategic recommendations to grow Maryland’s biohealth industry and position the state as a globally recognized Top 3 U.S. BioHealth Innovation Hub by 2023. Maryland is currently one of the most asset-rich states for biohealth in the nation, and is home to top federal agencies, like the National Institutes for Health, the U.S. Food and Drug Administration, and the National Cancer Institute; key federal research labs and world-class higher education institutions; and a confluence of more than 500 biohealth companies.

Read more ...


The Biohealth Capital Region Forum continued Thursday in Gaithersburg where guests heard from Senator Chris Van Hollen.   

One of the topics of the forum was funding for the biotech industry. Many national health companies are headquartered in Montgomery County and are concerned about federal funding. President Trump's proposed budget would cut six billion dollars from the National Institute of Health.

Read more ...


Out of five startup companies selected to present in front of a panel of industry leaders at the 2017 BioHealth Capital Region Forum, LifeSprout was chosen to have the most commercial potential at the 2nd Annual Crab Trap Competition.This year the event was moderated by BHI President & CEO, Rich Bendis. Judges included industry leaders from Verily Life Systems, Roche, Inova Strategic Investments, New Enterprise Associates, AstraZeneca, and Blu Venture Investors. LifeSprout impressed judges with a presentation by Kevin Colbert, Director of Operations, on their next-generation of synthetic soft tissue substitutes for aesthetic and reconstructive medicine. Their first-in-class bioresorbable, nanofiber-hydrogel composites are formulated to match the stiffness of native soft tissues without compromising their porosity.  LifeSprout is a Johns Hopkins University startup.

Read more ...


Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, is pleased to announce the winner of their Cancer Discovery Incubator Award, Midissia Therapeutics (Midissia). Midissia is a clinical stage immunotherapy start-up focused on immune intensification.

Currently, Midissia is based in San Francisco and incorporated in Delaware. Immunomic Therapeutics’ Cancer Discovery Incubator will provide Midissia with the opportunity to develop a proof-of-concept experiment in the Immunomic laboratories. Additionally, Midissia will receive funding, lab equipment and a unique mentorship with the Immunomic executive team for one year.

Read more ...


Looking for an investment? You're in luck: Chevy Chase-based venture juggernaut New Enterprise Associates is wrapping up its latest $3 billion fund.

The venture firm has completed a “first close,” which means NEA has finalized its capital commitments and can now make investments. The firm can still raise additional money and will probably conduct a final close in a matter of weeks, according to sources familiar with the company’s fundraising efforts.

Read more ...

puzzle blocks

March 27, 2017 – All the talk of digital disruption turning incumbents into dinosaurs and unicorns into masters of entirely new domains might lead you to think this is already an old narrative—so 2016. In fact, digitization has barely started, and so has the accompanying upheaval.

Digital technologies and processes have penetrated only about 35% of the way into the average industry, meaning that merely a third of a typical company’s products and operations that could be digitized have been. Yet the impact has already been dramatic: Globally, digital disruption is shaving 45% off incumbent companies’ revenue growth and 35% off their earnings before interest and taxes (EBIT).


Read more ...

Growing Innovation Smarts

The process of taking a technology from laboratory to market — a gap so fraught with pitfalls that some have dubbed it the ‘Valley of Death’ — is daunting to many academics who have no prior business experience.

In Singapore, help is at hand: The Singapore-MIT Alliance for Research and Technology (SMART) Innovation Centre is one of several institutions working with researchers to help them navigate the jump between an academic environment and the marketplace.


Read more ...


I know entrepreneurs who have suffered from premature execution often associated with the ready-fire-aim quick-to-market approach. Yet I believe that many more have benefited from this approach, especially in early startup stages. If your product is highly innovative, and speed to market is critical, you won’t get it right the first time anyway, no matter how cautiously you plan.


Read more ...